These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20569688)

  • 1. Pharma's developing interest in stem cells.
    McKernan R; McNeish J; Smith D
    Cell Stem Cell; 2010 Jun; 6(6):517-20. PubMed ID: 20569688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Funding translational work in cell-based therapy.
    Rao MS
    Cell Stem Cell; 2011 Jul; 9(1):7-10. PubMed ID: 21726828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deciphering the therapeutic stem cell strategies of large and midsize pharmaceutical firms.
    Vertès AA
    Regen Med; 2014; 9(4):479-95. PubMed ID: 25159065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 2. Pharma's challenges and their commitment to innovation.
    Abou-Gharbia M; Childers WE
    J Med Chem; 2014 Jul; 57(13):5525-53. PubMed ID: 24428137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem Cells - SMi's second annual conference: achieving success in science and commercialisation.
    Lucifero D
    IDrugs; 2010 Apr; 13(4):232-4. PubMed ID: 20373250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Big Pharma's small wonder.
    Fry E
    Fortune; 2014 Jun; 169(8):178-84, 186. PubMed ID: 25211849
    [No Abstract]   [Full Text] [Related]  

  • 7. Big pharma's struggles might benefit health plans.
    Manag Care; 2012 Jan; 21(1):65. PubMed ID: 22334941
    [No Abstract]   [Full Text] [Related]  

  • 8. Big Pharma's Commedia.
    Steele FR
    Cell; 2005 Dec; 123(6):971-3. PubMed ID: 16360023
    [No Abstract]   [Full Text] [Related]  

  • 9. The global cell therapy industry continues to rise during the second and third quarters of 2012.
    Mason C; McCall MJ; Culme-Seymour EJ; Suthasan S; Edwards-Parton S; Bonfiglio GA; Reeve BC
    Cell Stem Cell; 2012 Dec; 11(6):735-9. PubMed ID: 23217418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commercialization of trials for peripheral artery disease.
    Sherman W; Mazouz C; Deans R; Patel AN
    Cytotherapy; 2011 Nov; 13(10):1157-61. PubMed ID: 21999371
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug development for neglected diseases: pharma's influence.
    Lancet; 2010 Jan; 375(9708):2. PubMed ID: 20022100
    [No Abstract]   [Full Text] [Related]  

  • 12. Discovery of innovative therapeutics: today's realities and tomorrow's vision. 1. Criticisms faced by the pharmaceutical industry.
    Abou-Gharbia M; Childers WE
    J Med Chem; 2013 Jul; 56(14):5659-72. PubMed ID: 23557017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bad medicine. Big Pharma's cash injections lead to poor ethical outcomes.
    Sloane T
    Mod Healthc; 2006 Aug; 36(31):19. PubMed ID: 16958350
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharma's year of trouble and strife.
    Frantz S
    Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339
    [No Abstract]   [Full Text] [Related]  

  • 15. Payers may cloud pharma's sunny outlook.
    Manag Care; 2015 Jul; 24(7):45. PubMed ID: 26281472
    [No Abstract]   [Full Text] [Related]  

  • 16. Balancing Big Pharma's books.
    Jack A
    BMJ; 2008 Feb; 336(7641):418-9. PubMed ID: 18292166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell technology for drug discovery and development.
    Hook LA
    Drug Discov Today; 2012 Apr; 17(7-8):336-42. PubMed ID: 22100998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cells in drug discovery, tissue engineering, and regenerative medicine: emerging opportunities and challenges.
    Nirmalanandhan VS; Sittampalam GS
    J Biomol Screen; 2009 Aug; 14(7):755-68. PubMed ID: 19675315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Industry influence. Big Pharma's long tentacles.
    Aldis WL
    BMJ; 2010 Feb; 340():c941. PubMed ID: 20160329
    [No Abstract]   [Full Text] [Related]  

  • 20. IT solutions for big Pharma's big headache.
    Krohn R
    J Healthc Inf Manag; 2005; 19(1):13-5. PubMed ID: 15682670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.